NYSE:DHRLife Sciences
What Danaher (DHR)'s CEO Transition To Diagnostics Leader Julie Sawyer Montgomery Means For Shareholders
Danaher Corporation recently announced that its Board appointed Julie Sawyer Montgomery as President, Chief Executive Officer, and Board member, effective October 1, 2026, with outgoing CEO Rainer Blair remaining as senior advisor until March 31, 2027 to support the leadership transition.
Sawyer Montgomery’s elevation to the top role follows her central role in expanding Danaher’s Diagnostics platform from about US$6.0 billion to about US$11.0 billion in revenue since 2017 and roughly...